A screening tool for psychological difficulties in children aged 6 to 36 months: cross-cultural validation in Kenya, Cambodia and Uganda.


Journal

BMC pediatrics
ISSN: 1471-2431
Titre abrégé: BMC Pediatr
Pays: England
ID NLM: 100967804

Informations de publication

Date de publication:
12 04 2019
Historique:
received: 25 09 2018
accepted: 14 03 2019
entrez: 14 4 2019
pubmed: 14 4 2019
medline: 12 5 2020
Statut: epublish

Résumé

In low-resource settings, the lack of mental health professionals and cross-culturally validated screening instruments complicates mental health care delivery. This is especially the case for very young children. Here, we aimed to develop and cross-culturally validate a simple and rapid tool, the PSYCa 6-36, that can be administered by non-professionals to screen for psychological difficulties among children aged six to 36 months. A primary validation of the PSYCa 6-36 was conducted in Kenya (n = 319 children aged 6 to 36 months; 2014), followed by additional validations in Kenya (n = 215; 2014) Cambodia (n = 189; 2015) and Uganda (n = 182; 2016). After informed consent, trained interviewers administered the PSYCa 6-36 to caregivers participating in the study. We assessed the psychometric properties of the PSYCa 6-36 and external validity was assessed by comparing the results of the PSYCa 6-36 against a clinical global impression severity [CGIS] score rated by an independent psychologist after a structured clinical interview with each participant. The PSYCa 6-36 showed satisfactory psychometric properties (Cronbach's alpha > 0.60 in Uganda and > 0.70 in Kenya and Cambodia), temporal stability (intra-class correlation coefficient [ICC] > 0.8), and inter-rater reliability (ICC from 0.6 in Uganda to 0.8 in Kenya). Psychologists identified psychological difficulties (CGIS score > 1) in 11 children (5.1%) in Kenya, 13 children (8.7%) in Cambodia and 15 (10.5%) in Uganda, with an area under the receiver operating characteristic curve of 0.65 in Uganda and 0.80 in Kenya and Cambodia. The PSYCa 6-36 allowed for rapid screening of psychological difficulties among children aged 6 to 36 months among the populations studied. Use of the tool also increased awareness of children's psychological difficulties and the importance of early recognition to prevent long-term consequences. The PSYCa 6-36 would benefit from further use and validation studies in popula`tions with higher prevalence of psychological difficulties.

Sections du résumé

BACKGROUND
In low-resource settings, the lack of mental health professionals and cross-culturally validated screening instruments complicates mental health care delivery. This is especially the case for very young children. Here, we aimed to develop and cross-culturally validate a simple and rapid tool, the PSYCa 6-36, that can be administered by non-professionals to screen for psychological difficulties among children aged six to 36 months.
METHODS
A primary validation of the PSYCa 6-36 was conducted in Kenya (n = 319 children aged 6 to 36 months; 2014), followed by additional validations in Kenya (n = 215; 2014) Cambodia (n = 189; 2015) and Uganda (n = 182; 2016). After informed consent, trained interviewers administered the PSYCa 6-36 to caregivers participating in the study. We assessed the psychometric properties of the PSYCa 6-36 and external validity was assessed by comparing the results of the PSYCa 6-36 against a clinical global impression severity [CGIS] score rated by an independent psychologist after a structured clinical interview with each participant.
RESULTS
The PSYCa 6-36 showed satisfactory psychometric properties (Cronbach's alpha > 0.60 in Uganda and > 0.70 in Kenya and Cambodia), temporal stability (intra-class correlation coefficient [ICC] > 0.8), and inter-rater reliability (ICC from 0.6 in Uganda to 0.8 in Kenya). Psychologists identified psychological difficulties (CGIS score > 1) in 11 children (5.1%) in Kenya, 13 children (8.7%) in Cambodia and 15 (10.5%) in Uganda, with an area under the receiver operating characteristic curve of 0.65 in Uganda and 0.80 in Kenya and Cambodia.
CONCLUSIONS
The PSYCa 6-36 allowed for rapid screening of psychological difficulties among children aged 6 to 36 months among the populations studied. Use of the tool also increased awareness of children's psychological difficulties and the importance of early recognition to prevent long-term consequences. The PSYCa 6-36 would benefit from further use and validation studies in popula`tions with higher prevalence of psychological difficulties.

Identifiants

pubmed: 30979364
doi: 10.1186/s12887-019-1461-3
pii: 10.1186/s12887-019-1461-3
pmc: PMC6460684
doi:

Types de publication

Journal Article Multicenter Study Research Support, Non-U.S. Gov't Validation Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

108

Références

BMC Public Health. 2012 Jul 23;12:541
pubmed: 22823941
Afr J Psychiatry (Johannesbg). 2010 Jul;13(3):192-203
pubmed: 20957318
Eur Child Adolesc Psychiatry. 2004 Dec;13(6):337-46
pubmed: 15619045
Lancet. 2007 Sep 8;370(9590):810-1
pubmed: 17804064
J Child Psychol Psychiatry. 2004 Jan;45(1):109-34
pubmed: 14959805
J Pediatr Psychol. 2004 Mar;29(2):143-55
pubmed: 15096535
J Child Psychol Psychiatry. 2007 Jan;48(1):62-70
pubmed: 17244271
Pediatrics. 2014 Jan;133(1):37-45
pubmed: 24366990
Lancet. 2007 Sep 8;370(9590):878-89
pubmed: 17804062
J Child Psychol Psychiatry. 2008 Mar;49(3):237-50
pubmed: 18333929
J Child Psychol Psychiatry. 2009 Jan;50(1-2):9-15
pubmed: 19175818
Int J Psychoanal. 1964 Oct;45:558-66
pubmed: 14236194
J Child Psychol Psychiatry. 1997 Jan;38(1):81-99
pubmed: 9232459
J Abnorm Child Psychol. 1997 Feb;25(1):59-64
pubmed: 9093900
Child Dev. 1996 Feb;67(1):218-35
pubmed: 8605830
Br J Psychiatry. 2000 Nov;177:396-401
pubmed: 11059991
Int J Methods Psychiatr Res. 2011 Dec;20(4):235-49
pubmed: 22020761
J Clin Epidemiol. 2009 Aug;62(8):797-806
pubmed: 19447581
Lancet. 2011 Oct 22;378(9801):1515-25
pubmed: 22008427
Eval Rev. 2007 Apr;31(2):153-65
pubmed: 17356181
Arch Pediatr Adolesc Med. 2012 Mar;166(3):276-81
pubmed: 22393184
J Abnorm Child Psychol. 2003 Oct;31(5):495-514
pubmed: 14561058
Glob Ment Health (Camb). 2015 May 19;2:e5
pubmed: 28596853
J Child Psychol Psychiatry. 2008 Mar;49(3):313-34
pubmed: 18093112
BMC Psychiatry. 2012 Oct 16;12:170
pubmed: 23072651
Value Health. 2005 Mar-Apr;8(2):94-104
pubmed: 15804318
Curr Opin Psychiatry. 2015 Jul;28(4):299-306
pubmed: 26001921
J Child Psychol Psychiatry. 2008 Mar;49(3):226-36
pubmed: 18221350
Infant Behav Dev. 2006 Jul;29(3):386-401
pubmed: 17138293
J Child Psychol Psychiatry. 2006 Mar-Apr;47(3-4):313-37
pubmed: 16492262
Psychol Bull. 1979 Mar;86(2):420-8
pubmed: 18839484
J Health Soc Behav. 2003 Sep;44(3):257-74
pubmed: 14582307
J Adv Nurs. 2007 May;58(4):386-95
pubmed: 17442038
J Pediatr Psychol. 1984 Jun;9(2):205-17
pubmed: 6470903
Int Health. 2015 Nov;7(6):438-46
pubmed: 25740941
Multivariate Behav Res. 1966 Apr 1;1(2):245-76
pubmed: 26828106
J Clin Child Psychol. 2000 Dec;29(4):569-77
pubmed: 11126634

Auteurs

Fabienne Nackers (F)

Epicentre, 8 rue Saint Sabin, 75011, Paris, France. Fabienne.Nackers@Brussels.msf.org.

Thomas Roederer (T)

Epicentre, 8 rue Saint Sabin, 75011, Paris, France.

Caroline Marquer (C)

Epicentre, 8 rue Saint Sabin, 75011, Paris, France.

Scholastic Ashaba (S)

Department of Psychiatry, Faculty of Medicine, Mbarara University of Science and Technology, P.O. Box 1410, Mbarara, Uganda.

Samuel Maling (S)

Department of Psychiatry, Faculty of Medicine, Mbarara University of Science and Technology, P.O. Box 1410, Mbarara, Uganda.

Juliet Mwanga-Amumpaire (J)

Epicentre, Mbarara Research Centre, P.O. Box 1956, Mbarara, Uganda.
Mbarara University of Science and Technology, P.O. Box 1404, Mbarara, Uganda.

Sothara Muny (S)

Medicine Department, Preah Kossamak Hospital, Ministry of Health, Phnom Pen, Cambodia.

Chea Sokeo (C)

Médecins Sans Frontières, Phnom Pen, Cambodia.

Vireak Shom (V)

Médecins Sans Frontières, Phnom Pen, Cambodia.

Maria Palha (M)

Médecins Sans Frontières, Phnom Pen, Cambodia.

Pauline Lefèbvre (P)

Médecins Sans Frontières, Phnom Pen, Cambodia.

Beatrice W Kirubi (BW)

Médecins Sans Frontières, Nairobi, Kenya.

Grace Kamidigo (G)

Médecins Sans Frontières, Nairobi, Kenya.

Bruno Falissard (B)

Centre de recherche en épidémiologie et santé des populations (CESP)/ Institut national de la santé et de la recherche médicale (INSERM) U1018, Maison de Solenn, Paris, France.

Marie-Rose Moro (MR)

Centre de recherche en épidémiologie et santé des populations (CESP)/ Institut national de la santé et de la recherche médicale (INSERM) U1018, Maison de Solenn, Paris, France.
Médecins Sans Frontières, Paris, France.
Université Paris Descartes, Sorbonne Paris Cité, Hôpital Cochin, Assistance Publique Hôpitaux de Paris, Paris, France.

Rebecca F Grais (RF)

Epicentre, 8 rue Saint Sabin, 75011, Paris, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH